Larvol Delta - CNS-Pharmaceuticals-Continues-Momentum-in-Ongoing-Potentially-Pivotal-Global-Trial-Evaluating-Berubicin-for-the-Treatment-of-GBM-with-First-Patient-Enrolled-in-Switzerland

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/cns-pharmaceuticals-continues-momentum-in-ongoing-potentially-pivotal-global-trial-evaluating-berubicin-for-the-treatment-of-gbm-with-first-patient-enrolled-in-switzerland-301766407.html

Mar 9, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next